Mucopolysaccharidosis & Macular Corneal Dystrophy: Clinical types & exam tips!
This video is an in‑depth, exam‑oriented teaching session on two important causes of corneal clouding that every ophthalmology trainee should be able to distinguish at the slit lamp: mucopolysaccharidoses (MPS) and macular corneal dystrophy. It is designed especially for residents, fellows, and FRCOphth candidates who want a high‑yield, clinically grounded approach to systemic storage diseases and stromal dystrophies with corneal opacification.
The session starts by setting out a clear framework for understanding mucopolysaccharidoses as lysosomal storage disorders caused by deficiencies of specific enzymes involved in glycosaminoglycan (GAG) degradation. This leads to progressive accumulation of dermatan, heparan, keratan, or chondroitin sulfate in multiple tissues including cornea, sclera, trabecular meshwork, and retina. The video walks through how this biochemical defect translates into the characteristic ophthalmic phenotype: diffuse corneal stromal clouding, thickened sclera, shallow anterior chamber in some types, raised intraocular pressure, and, in certain subtypes, pigmentary retinopathy and optic nerve involvement.
Candidates are guided through the key MPS types that show prominent ocular involvement, focusing on Hurler syndrome (MPS I), Hunter syndrome (MPS II), and Morquio syndrome (MPS IV). For each, the video highlights the typical age at presentation, systemic features such as coarse facies, organomegaly, dysostosis multiplex, joint stiffness or laxity, and the pattern of visual morbidity. Emphasis is placed on how to describe the cornea in the exam: the clouding is usually diffuse, stromal, often involving the full thickness, with a ground‑glass or “frosted” appearance, but usually with a normal epithelium. Candidates are reminded to link this to the underlying systemic diagnosis and to mention associated risks such as glaucoma and optic atrophy in their viva answers.
The video then transitions to macular corneal dystrophy (MCD), a recessively inherited stromal dystrophy associated with abnormal keratan sulfate metabolism. Unlike MPS, which is a multisystem storage disease, MCD is confined primarily to the cornea, but can cause significant visual loss from bilateral progressive stromal opacification. The lecture explains how MCD typically presents in the first or second decade with progressive visual blurring and photophobia, without systemic features, in contrast to the syndromic context of MPS.
A large part of the teaching focuses on pattern recognition at the slit lamp. Macular corneal dystrophy is described as showing central, often ill‑defined, gray‑white stromal opacities with intervening haze that gradually spreads to involve midperipheral and peripheral cornea. The opacities are often denser centrally and can extend to the full stromal depth and even into Descemet’s membrane and endothelium in advanced disease. The term “macular” refers to the patchy, macule‑like lesions rather than the retinal macula. In contrast to granular or lattice dystrophies, the deposits in MCD are more confluent, less sharply demarcated, and associated with diffuse background haze.
For exam purposes, the video systematically contrasts the corneal findings in MPS and MCD:
Systemic vs isolated:
MPS: Multisystem disease with skeletal, cardiac, respiratory, and neurological involvement.
MCD: Isolated corneal dystrophy without systemic abnormalities.
Age and presentation:
MPS: Often presents in childhood with developmental and systemic signs; corneal clouding may be recognized on pediatric assessment.
MCD: Often presents in late childhood or early adulthood with progressive visual symptoms and bilateral corneal changes.
Pattern of corneal opacification:
MPS: Diffuse, uniform stromal clouding, often from limbus to limbus, giving a hazy, ground‑glass cornea.
MCD: Irregular, patchy stromal opacities with macule‑like lesions and intervening haze, spreading from central to peripheral.
Associated ocular features:
MPS: Can be associated with thickened sclera, shallow chamber in some types, glaucoma, optic nerve involvement, and retinal degeneration.
MCD: Typically limited to corneal involvement; IOP and posterior segment are usually normal unless secondary pathology develops.
Systemic workup:
MPS: Requires urine GAG analysis, specific enzyme assays, and genetic testing; multidisciplinary systemic management is crucial.
MCD: Workup centers on family history, corneal imaging, and sometimes genetic tests; management is largely ophthalmic.
The video also offers practical FRCOphth exam tips on how to structure a viva answer. The instructor models how to describe a corneal photograph or slit‑lamp video concisely and logically: starting with laterality, distribution, depth, and density of opacification, then adding likely diagnosis and key differentials such as other stromal dystrophies, post‑infective scars, or metabolic storage disorders like MPS or cystinosis. The importance of correlating clinical context—age, systemic findings, family history, consanguinity—is stressed for distinguishing MPS from MCD at the table or in OSCE scenarios.
From a management perspective, the session reviews when to consider penetrating keratoplasty or deep anterior lamellar keratoplasty in macular corneal dystrophy, highlighting that recurrence in the graft can occur and that long‑term follow‑up is necessary. For MPS, corneal transplantation is discussed more cautiously, given the systemic nature of the disease and challenges with anesthesia, airway, cardiomyopathy, and postoperative care. The role of enzyme replacement therapy and hematopoietic stem cell transplantation in modifying the course of MPS is also noted, with the caveat that existing corneal clouding may not fully reverse and visual rehabilitation remains an important goal.
Throughout, the video keeps the tone highly exam‑relevant. Key buzzwords, classic descriptive phrases, and structured differentials are repeatedly emphasized to help trainees recall salient points under time pressure. Particular attention is given to how these conditions may appear in FRCOphth photographs, MCQs, and OSCE stations, and how to avoid common pitfalls—such as confusing macular corneal dystrophy with granular dystrophy, or assuming all bilateral clouding in a young patient is dystrophic rather than considering a systemic storage disorder.
If you are an ophthalmology trainee, FRCOphth candidate, or simply want to refine your approach to corneal opacification in systemic disease and hereditary dystrophies, this video provides a focused, clinically grounded overview. It combines morphology, pathophysiology, systemic associations, and management strategies to help you move from pattern recognition to confident diagnosis and exam‑ready explanations.
